Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder
Science & Technology News
In March 2024, CYB003 received U.S. Food and Drug Administration (“FDA”) Breakthrough Therapy Designation. Among its many benefits, this designation ...
